3,0
30. Aug. 2012
Ehemaliger Mitarbeiter, mehr als 10 Jahre
Rochester, NY
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
There are still some good people working at Novartis
Kontras
Poor pipeline management. They have many products in their pipeline but because of poor management they can't get them passed the FDA.